Canada markets close in 5 hours 8 minutes

AstraZeneca PLC (AZNCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
134.130.00 (0.00%)
As of 10:08AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close134.13
Open134.13
Bid0.00 x 0
Ask0.00 x 0
Day's Range134.13 - 134.13
52 Week Range105.26 - 143.90
Volume277
Avg. Volume2,653
Market Cap207.833B
Beta (5Y Monthly)0.12
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.85 (2.23%)
Ex-Dividend DateAug 11, 2022
1y Target EstN/A
  • Zacks

    Merck (MRK) Enters Into Circular RNA Collaboration With Orna

    Merck (MRK) is set to make an upfront payment of $150 million to Orna for rights to the latter's circular RNA technology to make vaccines and therapeutics for infectious disease and oncology.

  • Zacks

    AstraZeneca's (AZN) Lynparza sNDA Gets FDA Priority Tag

    FDA grants priority review to AstraZeneca (AZN) and Merck's (MRK) Lynparza as a combination therapy for patients with metastatic castration-resistant prostate cancer.

  • Motley Fool

    Why Gilead Sciences Stock Was a 5% Winner Today

    Gilead Sciences (NASDAQ: GILD) stock was off to a good start this week, rising by more than 5% on Monday against the modest (0.4%) gain of the S&P 500 index. The prominent pharmaceutical company had some good news to impart about an important cancer drug. Gilead announced that morning that its breast cancer treatment Trodelvy recorded "statistically significant and clinically meaningful" results in a phase 3 clinical trial.